Organization
Charité - Universitätsmedizin Berlin, Berlin, Germany
8 abstracts
Abstract
Dermatology-related quality of life outcomes in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: A prespecified secondary analysis of the phase 2 randomized PanaMa (AIO KRK 0212) trial.Org: Gesundheitszentrum St Marien, Amberg, Germany, Charité - Universitätsmedizin Berlin, Berlin, Germany, Charité-University madicine Berlin, Department of Hematology, Oncology and Tumorimmunology, Berlin, Germany, Practice of Hematology and Oncology (HOPE), Hamburg, Germany, Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany,
Abstract
Next generation CD44v6-specific CAR-NK cells for the treatment of solid tumors.Org: Charité University Medicine Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany,
Abstract
Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer.Org: University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, Division of Medical Oncology, National Cancer Center Singapore and Duke-NUS Medical School, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Oregon Health and Science University,
Abstract
Single nucleotide polymorphisms (SNPs) in MHC class I and II genes to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3, MAVERICC, and TRIBE trials.Org: Bayer AG, Charité - Universitätsmedizin Berlin, Berlin, Germany, University of Munich, University of Pisa & Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Germany,
Abstract
Larotrectinib (laro) long-term efficacy and safety in patients (pts) with tropomyosin receptor kinase (TRK) fusion thyroid carcinoma (TC).Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Medicine, Icahn School of Medicine at Mount Sinai, Massachusetts General Hospital, Harvard Medical School, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy,
Abstract
Incidence of synchronous and metachronous peritoneal metastases for gallblader cancer: A single-center cohort analysis.Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Chirurgische Klinik, Campus Virchow Klinikum, Charité– Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin and Humboldt-Universitaet Zu Berlin,
Abstract
Incidence of metachronous peritoneal metastases for intrahepatic cholangiocarcinoma after curative resection: A single center cohort analysis.Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Chirurgische Klinik, Charité– Universitaetsmedizin Berlin, Medizinische Hochschule Hannover, Charite-Universitätsmedizin Berlin, Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Berlin, Germany,
Abstract
Uterine sarcoma patients who underwent morcellation: Who are they? Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA- NOGGO RU1).Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Helios Klinikum Berlin-Buch, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Tuebingen University Hospital,